Skip to Content

A Tale of Two Drugs

November 2013

Today’s medicines can cost hundreds of thousands of dollars a year. The story of how two companies set prices for their costly new drugs suggests that the way we determine the value of such treatments will help decide the future of our health-care system.

Read the issue

Letter from the editor

The Legacy of Ann Wolpert

Features

  • Categorized in 17035

    A Tale of Two Drugs

    Today’s medicines can cost hundreds of thousands of dollars a year. The story of how two companies set prices for their costly new drugs suggests that the way we determine the value of such treatments will help decide the future of our health-care system.
  • As Web companies and government agencies analyze ever more information about our lives, it’s tempting to respond by passing new privacy laws or creating mechanisms that pay us for our data. Instead, we need a civic solution, because democracy is at risk.
  • Categorized in 17032

    The Decline of Wikipedia

    The community that built the largest encyclopedia in history is shrinking, even as more people and Internet services depend on it than ever. Can it be revived, or is this the end of the Web’s idealistic era?

Past issues

    Updated